Search

Your search keyword '"Jung Young Shin"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Jung Young Shin" Remove constraint Author: "Jung Young Shin"
57 results on '"Jung Young Shin"'

Search Results

1. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

2. Synergistic Antitumor Effect of Taxanes and CDK4/6 Inhibitor in Lung Cancer Cells and Mice Harboring KRAS Mutations

3. Abstract 2232: The identification of novel autophagy flux-related molecules closely linked to the acquired resistance to EGFR TKIs in NSCLC patients harboring EGFR mutations

4. Abstract 1582: Inhibition of autophagy by CAGE targeting peptide retard tumor growth in non-small cell lung cancer of EGFR TKI resistance

5. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

6. Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer

7. Additional file 2 of Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

9. Additional file 3 of Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

10. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients

11. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft lung cancer mouse model

12. A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients

13. Abstract 3046: Anti-tumor efficacy of CKD-702 in EGFR TKI-resistant patient-derived xenograft model

14. Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy

15. A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS

16. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes

17. The transcriptional landscape and mutational profile of lung adenocarcinoma

18. Pharmacogenetic Impact on Korean Patients Receiving Antiepileptic Drugs

19. Association of Genetic Variations with Pemetrexed-Induced Cytotoxicity in Non-Small Cell Lung Cancer Cells

20. KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas

21. Coexistence of rearranged during transfection (RET) variants and activating EGFR mutations with their molecular implications in lung adenocarcinomas

22. Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

23. Detection of RET (rearranged during transfection) variants and their downstream signal molecules in RET rearranged lung adenocarcinoma patients.

24. Abstract 2832: Synergistic effect of combined cdk4/6 inhibitor with docetaxel in lung cancer cell lines harboring KRAS mutations

25. Abstract 1687: KIF5B-RET fusion gene may induce EMT via the regulation of two transcription factors, FOXA2 and STAT5A

26. EGFR mutations in tumor tissue and blood collected from lung cancer patients by Insight Onco NGS technique

27. The upregulation of FOXA2 transcription factor in RET rearranged lung adenocarcinoma

28. Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations

29. Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients

30. Abstract 2710: Tumorigenic activity of a novel KIF5B-RET fusion gene

31. The clinical characteristics of RET rearranged lung adenocarcinoma patients

32. KIF5B-RET fusion gene and oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas

34. R497K of EGFR and BIM deletion polymorphisms as predictive biomarkers to EGFR TKIs in NSCLCs harboring wild-type EGFR

35. Two genetic polymorphisms of EGFR as useful predictive biomarkers for NSCLC patients receiving EGFR TKIs

36. Abstract 185: Alteration of microRNA expression profiles in HPV-associated squamous cell carcinoma of the head and neck (SCCHN)

37. Abstract 1291: Tumor growth inhibitory effect in EIF4B silenced in vitro and in vivo lung cancer models

38. Abstract 4896: Synergistic anti-tumor activity of CDK4/6 inhibitor combined with paclitaxel in NSCLC cells harboring mutant KRAS

39. Bevacizumab activity in gastric cancer cells with high expression of VEGF

40. Abstract A66: Antiproliferative effects of CDK4/6 inhibition alone and combination with chemotherapy in KRAS-mutated NSCLC

41. Association of CA repeat number and R497K with PFS to EGFR TKIs in NSCLC patients having sensitive mutation of EGFR

42. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells

43. Abstract 3618: Synergistic anti-tumor efficacy of a multi kinase inhibitor, Sorafenib combined with Paclitaxel in vitro and in vivo lung cancer models

44. Abstract 1582: Rho GDP dissociation inhibitor 2 (RhoGDI2) plays a functionally important role on EGFR signaling pathway in adenocarcinoma cells of lung cancer

45. Influence of Reduced Folate Carrier and Dihydrofolate Reductase Genes on Methotrexate-Induced Cytotoxicity

46. Abstract A81: Synergistic antitumor efficacy of the multikinase inhibitor, sorafenib and paclitaxel combination in NSCLC tumor model

47. Comparison of three different methods for the detection of human papillomavirus infected in cervical lesions

48. KIF5B-RET Fusion gene may coincide oncogenic mutations of or gene EGFR KRAS in lung adenocarcinomas.

49. KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas.

50. Codon 618 mutation of the RET protooncogene in exon 10 is a good indication of prophylatic thyroidectomy for patients with familial medullary thyroid cancer

Catalog

Books, media, physical & digital resources